BIOGEN INC

Biogen insider buying spikes: William A. Hawkins and execs buy shares post‑Apellis deal, signaling confidence in Biogen’s growth and value potential.

Biogen insider activity: C.A.O. Sean Godbout buys and sells shares amid Apellis acquisition, revealing cautious optimism and potential upside.

Biogen CEO’s Feb 6 insider trades show confidence, but routine vesting dominates – a modest 20% stake increase that’s unlikely to sway the market.

Biogen insider buy signals confidence before earnings; investors weigh this buy with Biogen’s growth prospects and sector trends.